---
title: "Gaxos.ai Inc. Raises $3.6 Million in Gross Proceeds from Warrant Exercise Transaction"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296142698.md"
description: "Gaxos.ai Inc. (NASDAQ: GXAI) completed the exercise of outstanding warrants, raising $3.6 million in gross proceeds. The transaction involved 3,007,654 common stock shares with reduced exercise prices ranging from $1.20 to $3.32 per share. These shares are registered under Forms S-1 and S-3."
datetime: "2026-08-17T20:06:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296142698.md)
  - [en](https://longbridge.com/en/news/296142698.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296142698.md)
generator: "portal-rs"
---

# Gaxos.ai Inc. Raises $3.6 Million in Gross Proceeds from Warrant Exercise Transaction

In Roseland, NJ on Aug. 17, 2026, Gaxos.ai Inc. (NASDAQ: GXAI) revealed the completion of the exercise of outstanding warrants. The warrants allowed the purchase of up to 3,007,654 common stock shares initially issued in Dec. 2024 and Sep. 2024. These warrants had exercise prices between $2.33 to $3.32 per share, now reduced to $1.20 per share. The common stock shares available upon warrant exercise are registered under Form S-1 (No. 333-292709) and Form S-3 (File No. 333-282739). Gaxos is a company focusing on AI applications in diverse high-growth sectors.

### Related Stocks

- [GXAI.US](https://longbridge.com/en/quote/GXAI.US.md)

## Related News & Research

- [Gaxos.ai closes warrant exercise at reduced $1.2 per share](https://longbridge.com/en/news/296140843.md)
- [Rainier Acquisition announces separation of IPO units](https://longbridge.com/en/news/298769523.md)
- [Cabaletta Bio raises $128.2 million from common stock warrant exercises](https://longbridge.com/en/news/298915127.md)
- [Zealand Pharma raises DKK 4,580,532 from employee warrant exercises](https://longbridge.com/en/news/298615228.md)
- [Conexeu Sciences issues 762,608 unregistered shares at US$2.3 in warrant exercise incentive program](https://longbridge.com/en/news/298641692.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**